May 13 (Reuters)-
Immuno Biological Laboratories Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2016 Mar 31, 2015 Mar 31, 2017 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 717 mln 729 mln 800 mln
(-1.6 pct) (+8.7 pct) (+11.5 pct)
Operating loss 75 mln loss 181 mln loss 180 mln
Recurring loss 81 mln loss 139 mln loss 180 mln
Net
Net loss 31 mln loss 158 mln loss 190 mln
EPS loss 4.86 yen loss 24.20 yen loss 28.14 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Immuno Biological Laboratories Co Ltd.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T
((Tokyo Headline News Desk +813 6441 1812))